Prev Arrow Stocks

IDEXX Laboratories Inc. ($IDXX) Stock Forecast: Up 0.1% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is IDEXX Laboratories Inc.?

IDXX (NASDAQ:IDXX) operates in the animal health industry and is recognized for its innovative solutions and strong financial performance. The market for animal health products is expanding steadily due to rising pet ownership and growing awareness about animal welfare.

Why is IDEXX Laboratories Inc. going up?

IDXX stock is up 0.1% on Nov 3, 2025 19:46

  • IDXX stock witnessed a notable upturn today after announcing impressive Q3 earnings that surpassed expectations, along with an optimistic future forecast.
  • The company disclosed adjusted earnings of $3.22 per share, marking a 15% year-over-year increase and exceeding analyst estimates.
  • Analysts had predicted earnings of $3.14 per share, underscoring confidence in the company's ability to deliver robust financial results.
  • Top Wall Street analysts have upgraded their outlook on IDXX, reflecting an increasing bullish sentiment among investors.

IDXX Price Chart

IDXX Technical Analysis

IDXX News

Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings - IDEXX Laboratories ( NASDAQ:IDXX )

IDEXX Laboratories Inc.'s ( NASDAQ:IDXX ) stock is trading higher on Monday after it reported better-than-expected third-quarter financial results and raised its 2025 forecast. The animal health company reported third-quarter 2025 adjusted earnings of $3.22 per share, up 15% year over year, ...

https://www.benzinga.com/markets/earnings/25/11/48594736/idexx-laboratories-extends-rally-following-upbeat-q3-earnings-outlook

0 News Article Image Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings - IDEXX Laboratories  ( NASDAQ:IDXX )

IDEXX Laboratories Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - IDEXX Laboratories ( NASDAQ:IDXX )

IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) will release earnings results for the third quarter, before the opening bell on Monday, Nov. 3. Analysts expect the Westbrook, Maine-based company to report quarterly earnings at $3.14 per share, up from $2.80 per share in the year-ago period.

https://www.benzinga.com/analyst-stock-ratings/price-target/25/11/48582969/idexx-laboratories-gears-up-for-q3-print-here-are-the-recent-forecast-changes-

1 News Article Image IDEXX Laboratories Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - IDEXX Laboratories  ( NASDAQ:IDXX )

ON Semiconductor, Williams Companies And 3 Stocks To Watch Heading Into Monday - ON Semiconductor ( NASDAQ:ON )

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Williams Companies Inc ( NYSE:WMB ) to report quarterly earnings at 51 cents per share on revenue of $2.89 billion after the closing bell, ...

https://www.benzinga.com/markets/equities/25/11/48582500/on-semiconductor-williams-companies-and-3-stocks-to-watch-heading-into-monday

2 News Article Image ON Semiconductor, Williams Companies And 3 Stocks To Watch Heading Into Monday - ON Semiconductor  ( NASDAQ:ON )

If You Invested $100 In IDEXX Laboratories Stock 10 Years Ago, You Would Have This Much Today - IDEXX Laboratories ( NASDAQ:IDXX )

IDEXX Laboratories ( NASDAQ:IDXX ) has outperformed the market over the past 10 years by 12.0% on an annualized basis producing an average annual return of 24.51%. Currently, IDEXX Laboratories has a market capitalization of $51.31 billion.

https://www.benzinga.com/insights/news/25/10/48560942/if-you-invested-100-in-idexx-laboratories-stock-10-years-ago-you-would-have-this-much-today

3 News Article Image If You Invested $100 In IDEXX Laboratories Stock 10 Years Ago, You Would Have This Much Today - IDEXX Laboratories  ( NASDAQ:IDXX )

This Hershey Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday - IDEXX Laboratories ( NASDAQ:IDXX ) , Hershey ( NYSE:HSY )

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

https://www.benzinga.com/analyst-stock-ratings/upgrades/25/10/48554492/this-hershey-analyst-is-no-longer-bearish-here-are-top-5-upgrades-for-friday

4 News Article Image This Hershey Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday - IDEXX Laboratories  ( NASDAQ:IDXX ) , Hershey  ( NYSE:HSY )

IDEXX Laboratories Inc. Price History

21.07.2024 - IDXX Stock was down 0.6%

  • The downward trend in IDXX today may be due to the following reasons:
  • Profit-taking: Investors who have realized substantial profits from holding IDXX stock for an extended period may have opted to sell shares to secure their gains, resulting in a decrease in the stock price.
  • Market correction: Following a period of sustained success, IDXX might be undergoing a natural market correction as investors review their positions and explore new investment prospects.
  • External influences: Economic conditions or industry-related developments could also be impacting the bearish movement in IDXX today, prompting investors to modify their investment portfolios accordingly.

30.00.2025 - IDXX Stock was up 5.2%

  • IDXX's upturn today is linked to market expectations of robust Q4 earnings, attributed to the company's successful execution of strategic initiatives.
  • Investors are positive about IDXX's outlook, anticipating growth and profitability in the upcoming period.
  • The favorable outlook for IDXX mirrors the market's confidence in the company's capability to deliver value and sustain a competitive position in the veterinary diagnostics sector.

03.10.2025 - IDXX Stock was up 1.5%

  • Expectations are high for IDEXX Laboratories' upcoming release of Q3 earnings, with analysts predicting an increase in quarterly earnings compared to the previous year. This optimistic forecast likely played a role in the recent bullish movement in the stock.
  • Over the past decade, IDXX has demonstrated impressive long-term performance, consistently outperforming the market and delivering substantial returns for investors. This consistent track record could be attracting more interest from investors.
  • A Hershey analyst's shift in sentiment towards IDEXX Laboratories, no longer holding a bearish view, combined with other top analyst upgrades, may be bolstering investor confidence in the company's future prospects and contributing to the current bullish trend in the stock.

03.10.2025 - IDXX Stock was up 0.1%

  • IDXX stock witnessed a notable upturn today after announcing impressive Q3 earnings that surpassed expectations, along with an optimistic future forecast.
  • The company disclosed adjusted earnings of $3.22 per share, marking a 15% year-over-year increase and exceeding analyst estimates.
  • Analysts had predicted earnings of $3.14 per share, underscoring confidence in the company's ability to deliver robust financial results.
  • Top Wall Street analysts have upgraded their outlook on IDXX, reflecting an increasing bullish sentiment among investors.

31.09.2024 - IDXX Stock was down 9.5%

  • Third-quarter earnings of IDXX surpassed adjusted EPS predictions but fell short of revenue consensus, hinting at possible hurdles in revenue expansion.
  • The deceleration in revenue growth is possibly linked to a decline in veterinary visits, influencing the company's sales trajectory.
  • Noteworthy growth in segments such as CAG and Water was eclipsed by the lower-than-expected revenue, possibly instigating a downward trend in the stock's value.
  • Concerns among investors about IDXX's future growth sustainability are palpable, with guidance adjustments contributing to the stock's market decline.

01.04.2025 - IDXX Stock was up 9.0%

  • IDEXX Laboratories has showcased an average annual return of 21.28% over the past 10 years.
  • The company boasts a market capitalization of $35.41 billion, indicating its market strength and resilience.
  • Today, IDXX experienced a bullish movement likely attributed to its consistent growth and robust financial performance that has attracted investors seeking high returns.

01.04.2025 - IDXX Stock was up 9.0%

  • Strong Q1 earnings were reported by IDXX, surpassing expectations and resulting in an increased outlook for the fiscal year 2025. This positive financial performance has led to heightened investor interest and a rise in the stock price.
  • Over the past decade, IDXX has consistently outperformed the market, achieving an impressive annualized return of 21.28%. This track record has likely fostered investor confidence in the company's future growth prospects.
  • The notable financial results and a history of market-beating returns have fueled a positive trend in IDXX stock, reflecting optimistic investor attitudes and confidence in the company's future prospects.

04.07.2025 - IDXX Stock was up 4.2%

  • IDEXX reported strong Q2 earnings, surpassing expectations with earnings of $3.50 per share and revenue reaching $1.11 billion.
  • The impressive 11% growth in Companion Animal Group sales contributed to the revenue increase, showcasing the company's strong performance in its core business segment.
  • The raised full-year EPS guidance and revenue forecast indicate a positive outlook for IDEXX, reassuring investors and justifying the premium valuation of the stock.
  • Overall, the market responded positively to IDEXX's robust financial results and optimistic future prospects, driving the stock price higher.

31.06.2025 - IDXX Stock was down 5.1%

  • Despite high expectations for Q2 earnings with anticipated growth in various segments, IDXX experienced a strong bearish movement today.
  • The market may have reacted negatively to the actual earnings release, which potentially fell short of the optimistic forecasts.
  • Investors might have been disappointed by certain aspects of the earnings report, such as lower-than-expected revenue or guidance for future performance.
  • It's possible that profit-taking or market dynamics unrelated to the company's fundamentals also contributed to the bearish movement in IDXX's stock price today.

06.07.2024 - IDXX Stock was up 5.3%

  • Following the impressive second-quarter results, IDXX stock demonstrated a bullish trend, surpassing estimates for both EPS and revenue.
  • The favorable earnings report, highlighted by exceeding EPS forecasts and revenue growth, likely enhanced investor confidence in the company's performance and future outlook.
  • Despite lowering its FY24 guidance in a separate update, the market primarily responded to the strong quarterly results, propelling a bullish sentiment in IDXX stock.
  • The failure to meet earnings and revenue projections in a different statement did not notably sway market sentiment towards IDXX today, as attention remained focused on the positive quarterly showing.

06.07.2024 - IDXX Stock was up 5.8%

  • Despite reducing its FY24 guidance and falling short of earnings projections, the robust revenue growth in the second quarter, notably in CAG and Water divisions, likely made a positive impression on investors.
  • The rescheduled earnings call possibly hinted at favorable developments or strategic changes within the company, prompting optimism among investors.
  • The market's positive response may suggest that investors are placing more emphasis on the company's future growth prospects and innovative solutions rather than immediate financial setbacks.

05.07.2025 - IDXX Stock was down 5.6%

  • IDEXX Laboratories (IDXX) stock experienced a bearish movement despite surpassing earnings expectations and posting strong Q2 results.
  • The market may have reacted negatively due to profit-taking by investors after a period of growth following the positive earnings report.
  • Despite the positive news of revenue growth, EPS beat, and raised guidance, the stock might have been impacted by broader market trends or sector rotation.
  • Investors might be cautious about the stock's valuation or potential future challenges despite the company's strong performance.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.